Zichun Hua Selected Research

microfibrillar protein

1/2022

MAGP2 induces tumor progression by enhancing uPAR-mediated cell proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zichun Hua Research Topics

Disease

43	Neoplasms (Cancer) 10/2024 - 10/2007
11	Melanoma (Melanoma, Malignant) 04/2024 - 01/2013
9	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2013
5	Colitis 10/2023 - 05/2014
3	Inflammation (Inflammations) 10/2023 - 11/2012
3	Fibrosis (Cirrhosis) 01/2023 - 03/2010
3	Colorectal Neoplasms (Colorectal Cancer) 08/2017 - 01/2015
3	Necrosis 06/2017 - 07/2005
3	Lung Neoplasms (Lung Cancer) 01/2015 - 04/2011
3	Arthritis (Polyarthritis) 11/2012 - 03/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2023 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 01/2019
2	Carcinogenesis 01/2021 - 10/2013
2	Breast Neoplasms (Breast Cancer) 10/2017 - 01/2015
2	Stroke (Strokes) 01/2016 - 01/2009
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 01/2015
2	Experimental Arthritis 11/2012 - 03/2012
2	Hyperglycemia 05/2012 - 02/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2010 - 03/2010
2	Infarction (Infarctions) 03/2010 - 01/2009
2	Brain Ischemia (Cerebral Ischemia) 01/2009 - 10/2008
2	Ischemia 01/2009 - 09/2004
2	Hepatocellular Carcinoma (Hepatoma) 08/2006 - 04/2003
1	Myeloid Leukemia (Leukemia, Myelocytic) 02/2024
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2024
1	Dysbiosis 10/2023
1	Chronic Renal Insufficiency 01/2023
1	Nephritis 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Hypoxia (Hypoxemia) 12/2022
1	Hypersensitivity (Allergy) 01/2022
1	Glioma (Gliomas) 01/2022
1	Bacterial Infections (Bacterial Infection) 10/2021
1	Lymphatic Metastasis 01/2020

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2012
7	LigandsIBA 01/2021 - 01/2012
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2007
6	Peptides (Polypeptides)IBA 11/2018 - 10/2007
5	VNP 20009 (VNP20009)IBA 04/2024 - 01/2016
4	CytokinesIBA 10/2023 - 04/2004
4	Small Interfering RNA (siRNA)IBA 01/2019 - 09/2008
3	ResveratrolIBA 12/2023 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2016
3	Annexin A5IBA 01/2021 - 01/2015
3	IntegrinsIBA 01/2015 - 10/2007
3	CollagenIBA 11/2012 - 03/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 08/2017
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2023 - 01/2016
2	5- (4- hydroxyphenyl)- 3H- 1,2- dithiole- 3- thioneIBA 10/2023 - 01/2016
2	Dextrans (Dextran)FDA Link 10/2023 - 05/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 08/2023 - 10/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 06/2017
2	Caspase 3 (Caspase-3)IBA 12/2022 - 04/2011
2	Angiogenesis InhibitorsIBA 12/2022 - 06/2017
2	Therapeutic UsesIBA 06/2022 - 01/2021
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 05/2012
2	Insulin (Novolin)FDA Link 12/2018 - 02/2012
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 04/2011
2	CD13 Antigens (Alanine Aminopeptidase)IBA 03/2014 - 01/2012
2	FlavonoidsIBA 05/2013 - 01/2013
2	galanginIBA 05/2013 - 01/2013
2	VaccinesIBA 09/2011 - 01/2011
2	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2010 - 03/2010
1	ZincIBA 02/2024
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2023
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2023
1	Fatty Acid-Binding ProteinsIBA 12/2023
1	2-MethoxyestradiolIBA 12/2023
1	CateninsIBA 12/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2023
1	NF-kappa B (NF-kB)IBA 10/2023
1	GasotransmittersIBA 10/2023
1	Collagen Type IV (Type IV Collagen)IBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	Methenamine (Hexamine)IBA 01/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	Periodic AcidIBA 01/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2022
1	type IV collagen alpha3 chain (Goodpasture antigen)IBA 12/2022
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 12/2022
1	AnnexinsIBA 06/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	microfibrillar proteinIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	Disulfiram (Antabuse)FDA Link 01/2022
1	FlagellinIBA 10/2021
1	Long Noncoding RNAIBA 01/2021
1	human MIRN124-2 microRNAIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2019

Therapy/Procedure

21	Therapeutics 10/2024 - 07/2006
3	Immunotherapy 10/2024 - 10/2022
3	Drug Therapy (Chemotherapy) 08/2017 - 04/2011
2	Photothermal Therapy 11/2018 - 11/2018
2	Intravenous Injections 08/2017 - 01/2016
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2023